Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
62.75    0.00 (0.00%)
Bid:
61.50
Ask:
64.00
Spread: 2.50 (4.065%)
Market Cap: £5.76m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Barclaycard

15 Feb 2012 07:00

RNS Number : 4306X
CPPGroup Plc
15 February 2012
 

 

 

CPPGroup Plc

15th February 2012

Barclaycard

CPP Group ("CPP or "the Group") announces that it has been informed by Barclaycard, one of its business partners, that following a competitive tender in line with its normal business practice, it does not intend to renew its contract when it expires on 31 March 2012.

In April last year CPP announced that Barclaycard had decided to stop sales in the call to confirm channel operated by the Group whilst it completed a review of the channel. Since that announcement, the Group has continued to offer Card Protection to Barclaycard customers who currently hold the Identity Protection product and who call the Group's customer service department and Barclaycard has continued to offer Identity Protection and Card Protection to its customers in all their existing channels.

The loss of this contract means that new sales of the Group's Card Protection and Identity Protection products to Barclaycard's customers will cease although renewals to the existing back book of Barclaycard customers will continue for a period of at least three years. The exact timing of the cessation of new sales has yet to be determined, but is likely to be within 3 to 6 months of the date of this announcement.

New policy sales to Barclaycard customers were estimated to be less than 1% of Group revenue in 2012. The impact of this change on underlying operating profit in 2012 and 2013 will not be material due to savings in commissions and marketing costs, although reduced sales in 2012 and 2013 will have an adverse impact on revenue and profitability beyond 2012 as the renewals revenues (upon which CPP pays a smaller commission to its Business Partners) will also be lower.

The FSA investigation into certain issues surrounding the sale of the Group's Card Protection and Identity Protection products in the UK, and the suspension of Identity Protection sales in the Group's UK voice channels, both of which were announced in March 2011, are continuing to have a material impact on the Group's ability to sell its full range of products in the UK. The duration and outcome of the FSA investigation continues to be uncertain.

Whilst disappointed at Barclaycard's decision, the Board remains positive about the Group's prospects in the UK as the new business pipeline continues to build, the consumer appeal of the Group's products remains strong, and relationships with business partners remain good. Meanwhile the Group's long-term international prospects continue to develop well in markets where the large bankable populations offer significant potential for further market penetration.

 

 

Enquiries

 

CPPGroup

Paul Stobart, Group Chief Executive

Shaun Parker, Chief Financial Officer

Tel: +44 (0)1904 544702

 

Tulchan Communications

John Sunnucks

David Allchurch

Martin Robinson

Tel. +44 (0)20 7353 4200

 

 

Notes to editors:

 

CPP is a leading international Life Assistance business with operations in 15 countries in both developed and developing markets. CPP's products and services are designed to meet consumer needs across a range of requirements, in particular relating to credit and debit card ownership, personal identity, mobile telephones, travel and the home. The Group primarily focuses on providing customer assistance during stressful life events such as losing or having a wallet, purse, mobile telephone or keys stolen, as well as support in the event of identity theft.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFDFWLFESELE
Date   Source Headline
4th Sep 20197:00 amRNSHalf-year Report
12th Aug 20194:09 pmRNSBlock listing Interim Review
1st Jul 20194:30 pmRNSTotal Voting Rights
1st Jul 20194:21 pmRNSBlock listing Interim Review
17th Jun 20192:36 pmRNSDirector/PDMR Shareholding
30th May 20194:41 pmRNSSecond Price Monitoring Extn
30th May 20194:35 pmRNSPrice Monitoring Extension
15th May 201910:09 amRNSPresentation at MELLO 2019
8th May 20199:36 amRNSAGM Statement
1st May 20193:39 pmRNSTotal Voting Rights
30th Apr 20193:39 pmRNSDirector/PDMR Shareholding
12th Apr 20199:56 amRNSAGM Statement
1st Apr 201910:17 amRNSTotal Voting Rights
27th Mar 20194:41 pmRNSSecond Price Monitoring Extn
27th Mar 20194:35 pmRNSPrice Monitoring Extension
27th Mar 20197:00 amRNSFinal Results
13th Mar 20192:25 pmRNSNotice of Results
12th Feb 201911:06 amRNSBlock listing Interim Review
4th Feb 20193:47 pmRNSTotal Voting Rights
21st Dec 20183:27 pmRNSDirector/PDMR Shareholding
21st Dec 20183:27 pmRNSDirector/PDMR Shareholding
20th Dec 20183:50 pmRNSDirector/PDMR Shareholding
20th Dec 20189:56 amRNSDirector/PDMR Shareholding
18th Dec 20182:48 pmRNSBlock listing Interim Review
5th Dec 20184:18 pmRNSHolding(s) in Company
4th Dec 20182:09 pmRNSTotal Voting Rights
1st Nov 20183:42 pmRNSTotal Voting Rights
2nd Oct 201812:41 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSHalf-year Report
13th Sep 20187:00 amRNSCPP investment boosts growth ambitions in India
3rd Sep 20184:57 pmRNSTotal Voting Rights
22nd Aug 20183:15 pmRNSAdditional Listing
13th Aug 20184:42 pmRNSBlock listing Interim Review
2nd Aug 20185:04 pmRNSTotal Voting Rights
11th Jul 20189:10 amRNSTotal Voting Rights
20th Jun 201811:06 amRNSBlock listing Interim Review
14th May 201810:45 amRNSDirector/PDMR Shareholding
9th May 20187:00 amRNSResult of AGM
25th Apr 20185:25 pmRNSDirector/PDMR Shareholding
5th Apr 201810:53 amRNSTotal Voting Rights
4th Apr 20189:00 amRNSNotice of AGM
19th Mar 201810:38 amRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAnnual Financial Report
2nd Mar 20184:51 pmRNSStatement re change of website address
19th Feb 20189:16 amRNSBlock listing Interim Review
2nd Jan 201810:16 amRNSTotal Voting Rights
18th Dec 20179:36 amRNSBlock listing Interim Review
12th Dec 201712:12 pmRNSDirector/PDMR Shareholding
7th Dec 20172:51 pmRNSStatement re FCA Approval
5th Dec 20172:48 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.